Myocarditis treating medicine

Abstract

The medicine for curing myocarditis is characterized by that it is an oral liquor or intravenous injection made up by using total saponin extracted from Chinese medicinal materials sweetvetch root and sterile physiological saline or phosphoric acid buffer solution through a certain preparation process. It possesses the obvious effect for resisting myocarditis virus and inhibiting pathopoiesis of Coxsackie B3 virus cell, as compared with virazole it possesses obvious protection action for myocarditis, and has no any toxic side effects.

Description

technical field [0001] The invention relates to a medicine for treating myocarditis, more specifically, the extract of the traditional Chinese medicine Radix Astragali as a medicine for treating myocarditis. Background technique [0002] Viral myocarditis is one of the diseases that cause high mortality in newborns and children. Most patients develop a chronic myocarditis process that eventually leads to cardiomyopathy. Even in developed countries with advanced medical care, the five-year survival rate of patients with cardiomyopathy is very low. The main reason for this process is that the early onset of myocarditis is easy to be ignored, and after the occurrence of cardiomyopathy in the protracted period of chronic myocarditis, there is a lack of survival. Effective drug treatment has caused no substantial progress in the treatment of myocarditis for many years, and has become one of the diseases that seriously endanger the physical and mental health of children and adole...

AI Technical Summary

Problems solved by technology

The effect of energy mixture is not good, and the side effects of antiviral drugs are relatively unsatisfactory, and some of them have been discontinued. The number of approved traditional Chinese medicines in China is very small, and the curative effect is not satisfactory, and the drugs for children are still blank.